Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Regencell Bioscience Holdings Ltd market cap is $69.36M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Regencell Bioscience Holdings Ltd 52 week high is $30.49 as of May 05, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Regencell Bioscience Holdings Ltd 52 week low is $3.16 as of May 05, 2024.
Regencell Bioscience Holdings Ltd stock price today is $5.33.
Regencell Bioscience Holdings Ltd stock price yesterday was $6.49.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Regencell Bioscience Holdings Ltd’s P/E ratio is -11.81.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Regencell Bioscience Holdings Ltd P/B ratio is 5.7653.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Regencell Bioscience Holdings Ltd's EBITDA is -52.93.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Regencell Bioscience Holdings Ltd 50-day moving average is $4.89.
Regencell Bioscience Holdings Ltd has 12 employees.